This federal contract award is for the supply of 135 doses of Fluorine-18 Fluorodeoxyglucose (F18 FDG) radiopharmaceutical, up to 15 millicuries per dose, to the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services. The contract has a ceiling value of $24,942.60 and is a firm fixed-price purchase order with an ultimate completion date of April 30, 2025. The prime contractor is Cardinal Health 414, LLC, a subsidiary of the global healthcare company Cardinal Health, Inc. No set-aside designation was used for this award. Cardinal Health 414 is an established supplier of radiopharmaceuticals and specialized medical products to various federal agencies, including the Department of Veterans Affairs (VA), Defense Health Agency (DHA), and NIAID, through multiple indefinite delivery vehicle (IDV) contracts.
Generated 1/30/25, 9:22 AM